CN Patent

CN108148085B — 具有抑制磷酸二酯酶4的化合物、制法及其药物用途

Assigned to Hefei Enruite Pharmaceutical Co Ltd · Expires 2019-11-01 · 7y expired

What this patent protects

本发明涉及药物化学领域，具体涉及一类具有抑制磷酸二酯酶4的小分子化合物(I)、制备方法及含有该化合物的药物组合物,药效学试验证明,本发明的化合物具有PDE‑4酶的抑制活性和炎症治疗功效。

USPTO Abstract

本发明涉及药物化学领域，具体涉及一类具有抑制磷酸二酯酶4的小分子化合物(I)、制备方法及含有该化合物的药物组合物,药效学试验证明,本发明的化合物具有PDE‑4酶的抑制活性和炎症治疗功效。

Drugs covered by this patent

Patent Metadata

Patent number
CN108148085B
Jurisdiction
CN
Classification
—
Expires
2019-11-01
Drug substance claim
No
Drug product claim
No
Assignee
Hefei Enruite Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.